ImmunityBio Inc. (IBRX)

ImmunityBio Inc. (IBRX $10.44)
- $10.44 Cap: $9.80B
- View IBRX Profile
- View Questions on IBRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

ImmunityBio Inc. (IBRX $10.44)
- $10.44 Cap: $9.80B
- View IBRX Profile
- View Questions on IBRX

Q: Could I have your thoughts on these two names (SLS & IBRX)? Would you buy them?

Read Answer Asked by Judith on February 25, 2026

GameStop Corporation (GME $24.20)
- $24.20 P/E (TTM): 26.56X Cap: $10.76B
- View GME Profile
- View Questions on GME
ImmunityBio Inc. (IBRX $10.44)
- $10.44 Cap: $9.80B
- View IBRX Profile
- View Questions on IBRX

Q: Could this finally the right time for IBRX to rebound? Why the sudden surge? Its been going sideways for a long time so after a huge 2 day run up is there much more upside? Thanks.

Read Answer Asked by Neeraj on January 22, 2026

ImmunityBio Inc. (IBRX $10.44)
- $10.44 Cap: $9.80B
- View IBRX Profile
- View Questions on IBRX

Q: Is ibrx a reasonable company to make a small investment in?
Its treatment anktiva is approved for some cancers already and appears to have broader applications. The patents seem to have about 10 years to run.
Thank you for your research and opinion.

Read Answer Asked by maida on December 02, 2025